Document is current
Any future updates will be listed below
-
Authors
Liu, Wei
Ge, Wenyi
Zhao, Qi
Fan, Xiaonong
Li, Yibing
Jia, Hongbo
Lei, Kangchen
Li, Songjiao
Li, Li
Du, Yuzheng
Liu, Jian
Shen, Yan
Yang, Sha
Wang, Shu
Jia, Xize
Ren, Lei
Liu, Jihua
-
Funding
Funding for this research was provided by:
Tianjin Science and Technology Plan Projects (21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890, 21JCZDJC00890)
National Key R & D Program of China (No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004, No. 2018YFC1705004)
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 20 September 2024
First Online: 4 October 2024
Declarations
:
: Ethical approval was granted on 9th November 2022 and revised on 5th May 2023 by the Ethics Committee of First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (Ethics Reference No: TYLL2022[K]No.032). All the participants will be given and signed a written consent form before being recruited into our study. In case of essential protocol modifications, a new version of the protocol with appropriate amendments will be submitted to the ethics committee for approval. Further studies may begin when the new protocol or changes to the existing protocol have been approved by the ethics committee. In addition, if administrative changes to the protocol are minor corrections and/or clarifications that have no effect on conducting the study, then these administrative changes will be agreed upon by the ethics committee, and will be documented in a memorandum. Substantive protocol amendments will also be transparently described in trial reports.
: Participants signed informed consent regarding publishing their photographs.
: The authors declare no competing interests.
